Category Archives: HIVMA

What we’re reading: Four decades of HIV have wrought remarkable change, continuing loss, remaining challenges

By on .

The Science Speaks editorial staff (me) took some time off to attend to some long overdue family business in Michigan, thanks to an uptick in vaccine uptake and access there, a place now emerging from a recent discouraging surge of transmissions. Enjoying the benefits the remarkable accomplishments of science and public health have given us offered […]

First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment

By on .

First long-acting injectable treatment for HIV represents an exciting step forward, should be optimized with equity, investment Dr. Rajesh Gandhi is the Co-Director of the Harvard Center for AIDS Research and the site leader of the MGH Clinical Research Site in the Harvard/Miriam AIDS Clinical Trials Unit and a scientific member of the Department of […]